Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Y Jeng

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Journal of Pediatric Surgery|May 17, 2000
Effect of CGS 26303, an endothelin-converting enzyme-neutral endopeptidase inhibitor, on nitrofen-induced congenital diaphragmatic hernia in the ratM Kavanagh, B Battistini, D Kluth, et al.
Journal of Pharmacological and Toxicological Methods|June 8, 2001
A novel procedure for daily measurements of hemodynamical, hematological, and biochemical parameters in conscious unrestrained ratsA Blouin, S Molez, D Pham, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Isoindolines: a new series of potent and selective endothelin-A receptor antagonistsP J Kukkola, N A Bilci, T Ikler, et al.
Endocrinology|June 1, 1989
Multiple forms of peptidyl alpha-amidating enzyme: purification from rat medullary thyroid carcinoma CA-77 cell-conditioned mediumJ P Gilligan, S J Lovato, N M Mehta, et al.
Biochemical Pharmacology|March 15, 1984
Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligandsP M Blumberg, S Jaken, B König, et al.
Agents and Actions|September 1, 1991
Interleukin-1-induced cartilage degradation is independent of substance P level in rabbit kneesE M O'Byrne, R L Goldberg, J R Doughty, et al.
Life Sciences|August 23, 2000
CGS 34043: a non-peptidic, potent and long-acting dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11A J Trapani, S De Lombaert, M E Beil, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzymeP J Kukkola, P Savage, Y Sakane, et al.
International Journal of Tissue Reactions|January 1, 1990
Increased intra-articular substance P and prostaglandin E2 following injection of interleukin-1 in rabbitsE M O'Byrne, V J Blancuzzi, D E Wilson, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat modelB Battistini, M Verreault, B Ayach, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Journal of Pediatric Surgery|May 17, 2000
Effect of CGS 26303, an endothelin-converting enzyme-neutral endopeptidase inhibitor, on nitrofen-induced congenital diaphragmatic hernia in the ratM Kavanagh, B Battistini, D Kluth, et al.
Journal of Pharmacological and Toxicological Methods|June 8, 2001
A novel procedure for daily measurements of hemodynamical, hematological, and biochemical parameters in conscious unrestrained ratsA Blouin, S Molez, D Pham, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Isoindolines: a new series of potent and selective endothelin-A receptor antagonistsP J Kukkola, N A Bilci, T Ikler, et al.
Endocrinology|June 1, 1989
Multiple forms of peptidyl alpha-amidating enzyme: purification from rat medullary thyroid carcinoma CA-77 cell-conditioned mediumJ P Gilligan, S J Lovato, N M Mehta, et al.
Biochemical Pharmacology|March 15, 1984
Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligandsP M Blumberg, S Jaken, B König, et al.
Agents and Actions|September 1, 1991
Interleukin-1-induced cartilage degradation is independent of substance P level in rabbit kneesE M O'Byrne, R L Goldberg, J R Doughty, et al.
Life Sciences|August 23, 2000
CGS 34043: a non-peptidic, potent and long-acting dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11A J Trapani, S De Lombaert, M E Beil, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzymeP J Kukkola, P Savage, Y Sakane, et al.
International Journal of Tissue Reactions|January 1, 1990
Increased intra-articular substance P and prostaglandin E2 following injection of interleukin-1 in rabbitsE M O'Byrne, V J Blancuzzi, D E Wilson, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat modelB Battistini, M Verreault, B Ayach, et al.
Pageof 10